159 related articles for article (PubMed ID: 32043469)
21. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus.
Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A
Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190
[TBL] [Abstract][Full Text] [Related]
22. Forced normalization of Lennox-Gastaut syndrome using lacosamide: A case report.
Ono-Takiguchi Y; Muramatsu K; Koshu K; Yamagata T
Brain Dev; 2021 Oct; 43(9):963-966. PubMed ID: 34049745
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience combined with therapeutic drug monitoring of lacosamide.
Svendsen T; Brodtkorb E; Baftiu A; Lossius MI; Nakken KO; Johannessen SI; Johannessen Landmark C
Acta Neurol Scand; 2020 Apr; 141(4):279-286. PubMed ID: 31853958
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus.
Koubeissi MZ; Mayor CL; Estephan B; Rashid S; Azar NJ
Acta Neurol Scand; 2011 Feb; 123(2):142-6. PubMed ID: 21198444
[TBL] [Abstract][Full Text] [Related]
25. Safety of Intravenous Push Lacosamide Compared With Intravenous Piggyback at a Tertiary Academic Medical Center.
McLaughlin K; Carabetta S; Hunt N; Schuler BR; Ting C; Tran LK; Szumita PM; Anger KE
Ann Pharmacother; 2021 Feb; 55(2):181-186. PubMed ID: 32686466
[TBL] [Abstract][Full Text] [Related]
26. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
Kellinghaus C; Berning S; Stögbauer F
Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
[TBL] [Abstract][Full Text] [Related]
27. Clinical management of elderly patients with epilepsy; the use of lacosamide in a single center setting.
Rainesalo S; Mäkinen J; Raitanen J; Peltola J
Epilepsy Behav; 2017 Oct; 75():86-89. PubMed ID: 28834781
[TBL] [Abstract][Full Text] [Related]
28. Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review.
Hawkes MA; Fernández Suárez M; Ugarnes G; D'Giano C
Clin Neuropharmacol; 2013; 36(4):138-40. PubMed ID: 23860347
[TBL] [Abstract][Full Text] [Related]
29. Status epilepticus developing during lacosamide monotherapy.
Papacostas SS
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25628098
[TBL] [Abstract][Full Text] [Related]
30. Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis.
Brigo F; Del Giovane C; Nardone R; Trinka E; Lattanzi S
Epilepsy Behav; 2019 Dec; 101(Pt B):106466. PubMed ID: 31462385
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of lacosamide and phenytoin in status epilepticus: A systematic review.
Panda PK; Panda P; Dawman L; Sharawat IK
Acta Neurol Scand; 2021 Oct; 144(4):366-374. PubMed ID: 33999428
[TBL] [Abstract][Full Text] [Related]
32. Intravenous lacosamide for treatment of status epilepticus.
Kellinghaus C; Berning S; Immisch I; Larch J; Rosenow F; Rossetti AO; Tilz C; Trinka E
Acta Neurol Scand; 2011 Feb; 123(2):137-41. PubMed ID: 20868429
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Tilz C; Resch R; Hofer T; Eggers C
Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
[TBL] [Abstract][Full Text] [Related]
34. Embolic brain infarction in nonrheumatic atrial fibrillation: a clinicopathologic study in the elderly.
Yamanouchi H; Nagura H; Mizutani T; Matsushita S; Esaki Y
Neurology; 1997 Jun; 48(6):1593-7. PubMed ID: 9191772
[TBL] [Abstract][Full Text] [Related]
35. Inverted-U response of lacosamide on pilocarpine-induced status epilepticus and oxidative stress in C57BL/6 mice is independent of hippocampal collapsin response mediator protein-2.
Nirwan N; Siraj F; Vohora D
Epilepsy Res; 2018 Sep; 145():93-101. PubMed ID: 29935443
[TBL] [Abstract][Full Text] [Related]
36. A novel action of lacosamide on GABA
Ruffolo G; Di Bonaventura C; Cifelli P; Roseti C; Fattouch J; Morano A; Limatola C; Aronica E; Palma E; Giallonardo AT
Neurobiol Dis; 2018 Jul; 115():59-68. PubMed ID: 29621596
[TBL] [Abstract][Full Text] [Related]
37. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study.
Poddar K; Sharma R; Ng YT
Pediatr Neurol; 2016 Aug; 61():83-6. PubMed ID: 27241232
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study.
Miró J; Toledo M; Santamarina E; Ricciardi AC; Villanueva V; Pato A; Ruiz J; Juvany R; Falip M
Seizure; 2013 Jan; 22(1):77-9. PubMed ID: 23127776
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience of intravenous lacosamide in infants and young children.
Arkilo D; Gustafson M; Ritter FJ
Eur J Paediatr Neurol; 2016 Mar; 20(2):212-217. PubMed ID: 26810009
[TBL] [Abstract][Full Text] [Related]
40. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
